Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 32; no. 15_suppl; p. 7510
Main Authors Eberhardt, Wilfried Ernst Erich, Gauler, Thomas Christoph, Pöttgen, Christoph, Friedel, Godehard, Veit, Stefanie, Heinrich, Vanessa, Welter, Stefan, Spengler, Werner, Kimmich, Martin, Fischer, Berthold, Schmidberger, Heinz, Gkika, Eleni, Cordes, Sebastian, Hepp, Rodrigo, Luetke-Brintrup, Diana, Lehmann, Nils, Schuler, Martin H., Jöckel, Karl-Heinz, Stamatis, Georgios, Stuschke, Martin
Format Journal Article
LanguageEnglish
Published 20.05.2014
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2014.32.15_suppl.7510